{
  "id": 12891330,
  "title": "J&J CEO Joaquin Duato on Obesity, Cancer and AI | The David Rubenstein Show",
  "url": "https://urgent.news/2026/10/08/j-j-ceo-joaquin-duato-on-obesity-cancer-and-ai-the-david-rubenstein",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-08T14:25:38.000Z",
  "source": {
    "name": "Bloomberg",
    "slug": "bloomberg",
    "url": "https://www.bloomberg.com/news/videos/2026-10-08/j-j-ceo-joaquin-duato-on-obesity-cancer-and-ai-video"
  },
  "original_language": "en",
  "account": null,
  "summary": "Johnson & Johnson CEO Joaquin Duato says the company has no plans to enter the obesity market, instead focusing on areas such as cancer. He says oncology remains one of J&J's core growth pillars, and highlights dementia as another major challenge for the healthcare industry. Duato also talked about how artificial intelligence could accelerate drug discovery and the development of new medicines.…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}